{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:40:57Z","timestamp":1792071657524,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s40744-022-00424-1","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T12:02:34Z","timestamp":1644321754000},"page":"763-770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels Cohort"],"prefix":"10.1007","volume":"9","author":[{"given":"Xavier","family":"Theunssens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bricman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Sapart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Sokolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Avramovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7156-2356","authenticated-orcid":false,"given":"Patrick","family":"Durez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"424_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cyto.2016.08.014","volume":"101","author":"H Mitoma","year":"2018","unstructured":"Mitoma H, Horiuchi T, et al. Molecular mechanisms of action of anti-TNF-\u03b1 agents \u2013 comparison. Cytokine. 2018;101:56\u201363.","journal-title":"Cytokine"},{"issue":"6","key":"424_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.rbr.2012.12.001","volume":"53","author":"L Goh","year":"2013","unstructured":"Goh L, Jewell T, et al. A systematic review of the influence of anti-TNF on infection rates in patients with rheumatoid arthritis. Rev Bras Reumatol. 2013;53(6):501\u201315.","journal-title":"Rev Bras Reumatol"},{"key":"424_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/joim.12991","volume":"288","author":"F Cohen Aubart","year":"2020","unstructured":"Cohen Aubart F, Lhote R, et al. Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database. J Intern Med. 2020;288:356\u201362.","journal-title":"J Intern Med"},{"key":"424_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/jcm10050983","volume":"10","author":"T Yamaguchi","year":"2021","unstructured":"Yamaguchi T, Costabel U, et al. Immunohistochemical detection of potential microbial antigens in granulomas in the diagnosis of sarcoidosis. J Clin Med. 2021;10:983.","journal-title":"J Clin Med"},{"key":"424_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMra2101555","volume":"385","author":"M Drent","year":"2021","unstructured":"Drent M, Crouser ED, et al. Challenges of sarcoidosis and its management. N Engl J Med. 2021;385:11.","journal-title":"N Engl J Med"},{"issue":"6","key":"424_CR6","doi-asserted-by":"publisher","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","volume":"58","author":"RP Baughman","year":"2021","unstructured":"Baughman RP, Valeyre D, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021;58(6):2004079.","journal-title":"Eur Respir J."},{"issue":"7","key":"424_CR7","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/art.23835","volume":"59","author":"AN Collamer","year":"2008","unstructured":"Collamer AN, Guerrero KT, Henning JS, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum. 2008;59(7):996\u20131001.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"424_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/rheumatology\/kep046","volume":"48","author":"CI Da\u00efen","year":"2009","unstructured":"Da\u00efen CI, Monnier A, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology. 2009;48(8):883\u20136.","journal-title":"Rheumatology"},{"issue":"13","key":"424_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1471-2377-13-212","volume":"28","author":"CA Durel","year":"2013","unstructured":"Durel CA, Feurer E, et al. Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis. BMC Neurol. 2013;28(13):212.","journal-title":"BMC Neurol"},{"issue":"7","key":"424_CR10","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1002\/art.11154","volume":"48","author":"O H\u00fcbscher","year":"2003","unstructured":"H\u00fcbscher O, Re R, et al. Pulmonary rheumatoid nodules in an etanercept-treated patient. Arthritis Rheum. 2003;48(7):2077\u20138.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"424_CR11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2169\/internalmedicine.47.0602","volume":"47","author":"T Ishiguro","year":"2008","unstructured":"Ishiguro T, Takayanagi N, et al. Development of sarcoidosis during etanercept therapy. Intern Med. 2008;47(11):1021\u20135.","journal-title":"Intern Med"},{"key":"424_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10067-010-1603-3","volume":"30","author":"T Kanellopoulou","year":"2011","unstructured":"Kanellopoulou T, et al. Sarcoid-like granulomatosis in patients treated with anti-TNF\u03b1 factors. A case report and review of the literature. Clin Rheumatol. 2011;30:581\u20133.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"424_CR13","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2169\/internalmedicine.2086-18","volume":"58","author":"T Isshiki","year":"2019","unstructured":"Isshiki T, Matsuyama H, et al. Development of propionibacterium acnes-associated sarcoidosis during etanercept therapy. Intern Med. 2019;58(10):1473\u20137.","journal-title":"Intern Med"},{"issue":"5","key":"424_CR14","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1378\/chest.122.5.1858","volume":"122","author":"L Peno-Green","year":"2002","unstructured":"Peno-Green L, Lluberas G, et al. Lung injury linked to etanercept therapy. Chest. 2002;122(5):1858\u201360.","journal-title":"Chest"},{"issue":"3","key":"424_CR15","first-page":"648","volume":"34","author":"A Kudrin","year":"2007","unstructured":"Kudrin A, Chilvers ER, et al. Sarcoid-like granulomatous disease following etanercept treatment for RA. J Rheumatol. 2007;34(3):648\u20139.","journal-title":"J Rheumatol"},{"issue":"1","key":"424_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.lpm.2014.06.028","volume":"44","author":"LM Scailteux","year":"2015","unstructured":"Scailteux LM, Guedes C, et al. Sarco\u00efdose survenant chez des patients trait\u00e9s par adalimumab pour un rhumatisme inflammatoire : \u00e0 propos de deux cas et revue de la litt\u00e9rature. Press Med. 2015;44(1):4\u201310.","journal-title":"Press Med"},{"issue":"4","key":"424_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.semarthrit.2008.11.003","volume":"39","author":"A Massara","year":"2010","unstructured":"Massara A, Cavazzini L, et al. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new \u201cclass effect\u201d paradoxical phenomenon. Two case reports and literature review. Semin Arthritis Rheum. 2010;39(4):313\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"424_CR18","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/1756-185X.12178","volume":"17","author":"R Miyagi","year":"2014","unstructured":"Miyagi R, Ideguchi H, et al. Development of pulmonary and cardiac sarcoidosis during etanercept therapy. Int J Rheum Dis. 2014;17(7):810\u20132.","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"424_CR19","doi-asserted-by":"publisher","first-page":"105183","DOI":"10.1016\/j.jbspin.2021.105183","volume":"88","author":"C Ngoufack","year":"2021","unstructured":"Ngoufack C, Semerano L, et al. Mitral valve granulomatosis: a paradoxical reaction complicating etanercept treatment in rheumatoid arthritis. Jt Bone Spine. 2021;88(4):105183.","journal-title":"Jt Bone Spine"},{"issue":"9","key":"424_CR20","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1007\/s10067-021-05654-2","volume":"40","author":"CI Rodrigues-Fernandes","year":"2021","unstructured":"Rodrigues-Fernandes CI, Migliorati CA, et al. Adalimumab-induced sarcoidosis-like reaction involving oral cavity in rheumatoid arthritis: a case-based review. Clin Rheumatol. 2021;40(9):3833\u20139.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"424_CR21","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/rheumatology\/ker166","volume":"50","author":"J Salvatierra","year":"2011","unstructured":"Salvatierra J, Magro-Checa C, et al. Acute sarcoidosis as parotid fever in rheumatoid arthritis under anti-tumor necrosis factor-alpha therapy. Rheumatology. 2011;50(7):1346\u20138.","journal-title":"Rheumatology"},{"issue":"2","key":"424_CR22","first-page":"178","volume":"33","author":"M Sawahata","year":"2016","unstructured":"Sawahata M, Sugiyama Y, et al. Sarcoidosis during etanercept treatment for rheumatoid arthritis in women with a history of bilateral oophorectomy. Sarcoidosis Vasc Diffuse Lung Dis. 2016;33(2):178\u201381.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"424_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/09273948.2011.623213","volume":"20","author":"P Seve","year":"2012","unstructured":"Seve P, Varron L, et al. Sarcoid-related uveitis occurring during adalimumab therapy. Ocul Immunol Inflamm. 2012;20(1):59\u201360.","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"424_CR24","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00296-009-1349-x","volume":"32","author":"IM Skoie","year":"2012","unstructured":"Skoie IM, Wildhagen K, et al. Development of sarcoidosis following etanercept treatment: a report of three cases. Rheumatol Int. 2012;32(4):1049\u201353.","journal-title":"Rheumatol Int"},{"issue":"11","key":"424_CR25","first-page":"2313","volume":"34","author":"G Sturfelt","year":"2007","unstructured":"Sturfelt G, Christensson B, et al. Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab. J Rheumatol. 2007;34(11):2313\u20134.","journal-title":"J Rheumatol"},{"issue":"1","key":"424_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1445-5994.2011.02612.x","volume":"42","author":"D Tong","year":"2012","unstructured":"Tong D, Manolios N, et al. New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication. Intern Med J. 2012;42(1):89\u201394.","journal-title":"Intern Med J"},{"issue":"6 Suppl 1","key":"424_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1590\/abd1806-4841.20132588","volume":"88","author":"N Unterstell","year":"2013","unstructured":"Unterstell N, Bressan AL, et al. Systemic sarcoidosis induced by etanercept: first Brazilian case report. An Bras Dermatol. 2013;88(6 Suppl 1):197\u20139.","journal-title":"An Bras Dermatol"},{"issue":"12","key":"424_CR28","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3899\/jrheum.090307","volume":"36","author":"D van der Stoep","year":"2009","unstructured":"van der Stoep D, Braunstahl GJ, et al. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge. J Rheumatol. 2009;36(12):2847\u20138.","journal-title":"J Rheumatol"},{"issue":"3","key":"424_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/thorax.58.3.278","volume":"58","author":"SR Vavricka","year":"2003","unstructured":"Vavricka SR, Wettstein T, et al. Pulmonary granulomas after tumour necrosis factor alpha antagonist therapy. Thorax. 2003;58(3):278\u20139.","journal-title":"Thorax"},{"key":"424_CR30","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s10067-007-0594-1","volume":"26","author":"K Verschueren","year":"2007","unstructured":"Verschueren K, et al. Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Clin Rheumatol. 2007;26:1969\u201371.","journal-title":"Clin Rheumatol"},{"key":"424_CR31","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3899\/jrheum.080383","volume":"35","author":"VM Ognenovski","year":"2008","unstructured":"Ognenovski VM, Ojo TC, et al. Etanercept-associated pulmonary granulomatous inflammation in patients with rheumatoid arthritis. J Rheumatol. 2008;35:2279\u201382.","journal-title":"J Rheumatol"},{"issue":"3","key":"424_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.rmr.2013.04.029","volume":"31","author":"A Watrin","year":"2014","unstructured":"Watrin A, Royer M, et al. Hypercalc\u00e9mie majeure r\u00e9v\u00e9latrice d\u2019une sarco\u00efdose induite par \u00e9tanercept [Severe hypercalcemia revealing sarcoidosis precipitated by etanercept]. Rev Mal Respir. 2014;31(3):255\u20138.","journal-title":"Rev Mal Respir"},{"key":"424_CR33","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.3390\/ijms22073705","volume":"22","author":"B Barna","year":"2021","unstructured":"Barna B, Malur A, Thomassen M. Studies in a murine granuloma model of instilled carbon nanotubes: relevance to sarcoidosis. Int J Mol Sci. 2021;22:3705.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"424_CR34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/MCP.0000000000000598","volume":"25","author":"M Terwiel","year":"2019","unstructured":"Terwiel M, Grutters JC, et al. Clustering of immune-mediated diseases in sarcoidosis. Curr Opin Pulm Med. 2019;25(5):539\u201353.","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"424_CR35","doi-asserted-by":"publisher","first-page":"2003468","DOI":"10.1183\/13993003.03468-2020","volume":"58","author":"R Lepzien","year":"2021","unstructured":"Lepzien R, Liu S, et al. Monocytes in sarcoidosis are potent TNF producers and predict disease outcome. Eur Respir J. 2021;58(1):2003468.","journal-title":"Eur Respir J"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-022-00424-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-022-00424-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-022-00424-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:11:06Z","timestamp":1648555866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-022-00424-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["424"],"URL":"https:\/\/doi.org\/10.1007\/s40744-022-00424-1","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"19 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}